
One-Dose Gene Therapy Cuts Alzheimer's Tau Protein 75%
A single intravenous treatment successfully reduced toxic tau protein by up to 75% in primate brains for six months, offering new hope for Alzheimer's patients. The breakthrough could eliminate the need for repeated invasive treatments.













